Navigation Links
Ex-Allergan Vice President Joins Kalologie Skincare Board of Directors
Date:3/19/2008

SANTA MONICA, Calif., March 19 /PRNewswire/ -- Kalologie Skincare today announced that Niv Edward Caviar, Executive Vice President of La Jolla Pharmaceutical Company, was elected to Kalologie Skincare's board of directors. Mr. Caviar previously served as Vice President of Allergan Inc.

"Niv is a strong marketer with solid operational skills," said William Brennan, Kalologie's CEO. "We look forward to benefiting from Niv's unique insight in the growing aesthetic skin care industry."

"Over the past five years, Kalologie has positioned itself to become a leading provider of aesthetic skin care products and services," said Niv Edward Caviar. "I look forward to working with the Company to help facilitate future growth, especially through the company's physician-only franchise program."

At Allergan, Mr. Caviar was Vice-President of Business Development and then Vice-President and Head of Marketing for Medical Dermatology. In his latter role, Mr. Caviar led all operational and strategic marketing activities for Allergan's U.S medical dermatology franchise. Brands under his responsibility included Tazorac(R), Avage(R), and Botox(R) for Medical Dermatology uses. Mr. Caviar is presently Executive Vice-President and Chief Business and Financial Officer of La Jolla Pharmaceutical Co., a San Diego-based biotech company focused on developing innovative pharmaceutical products. La Jolla Pharmaceutical's leading product in development is Riquent(R) (abetimus sodium), which is currently being studied to help treat and maintain remission in patients with lupus renal disease.

Mr. Caviar received an M.B.A. from Harvard University and a B.S. in Mechanical Engineering from the U.S. Air Force Academy. Prior to his work at Allergan, Mr. Caviar served as a captain in the U.S. Air Force where he worked as a Solid Rocket Motor Engineer and was a Project Manager for the U.S. Space Command on both the Titan IV Rocket and the Space Shuttle Solid Rocket Motor Programs.

Founded in 2003, Kalologie is a chain of comprehensive, one-stop skin care clinics offering effective medical and aesthetic skin care treatments such as Botox(R), Juvederm, Restylane, IPL Photo Facials, Laser Hair Removal, Facials and Chemical Peels. In addition the Company offers a proprietary line of Kalologie-branded skin care products.

Kalologie Franchising, LLC, with headquarters in Santa Monica, California, is a solution-oriented skin care company offering a comprehensive approach to address the unique challenges of each individual's skin. http://www.kalologie.com

For press inquiries, please contact Sarah Lopez; sarah_lopez@kalologie.com; (310) 961-2077.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Kalologie Franchising, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Three CEOs and University President Named Winners of Greater Baltimore Committees 2008 Baltimore Region Bioscience Awards
2. Dr. Linda McAllister Joins Arbor Vita Corporation as Vice President of Diagnostics
3. iCAD Appoints John DeLucia as Vice President of Quality Assurance and Regulatory Affairs
4. Cato Research Names John Cline as President
5. Matthew B. Potter Joins Pressure BioSciences, Inc. as Vice President of Sales
6. febit Appoints Michelle Lyles, Ph.D., Vice President, Marketing and Sales
7. Elusys Therapeutics Appoints Robert Gundel as Vice President of Research
8. Bristol-Myers Squibb Board Elects Jean-Marc Huet Senior Vice President and Chief Financial Officer
9. MiMedx Announces Brian J. Splan as President
10. Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
11. Onyx Pharmaceuticals Names N. Anthony Coles, M.D. as President, Chief Executive Officer and Member of its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... The immunohistochemistry (IHC) market is projected ... of 7.3% during the forecast period of 2016 to 2021 dominated ... accounted for the largest share of immunohistochemistry (IHC) market, by end ... , , ... market spread across 225 pages, profiling 10 companies and supported with ...
(Date:11/30/2016)... 30, 2016 The global Pyrogen ... hold a dominant share in the overall market. The ... Inc., and Merck KGaA, held a lion,s share of ... Research observes that these companies are expected to retain ... that are do not require rabbit pyrogen testing along ...
(Date:11/30/2016)... 30, 2016 /PRNewswire/ -  Equicare Health Inc ., the ... recognized as one of the top 100 companies in ... listing that distinguishes the top digital health companies across ... step forward this year continually upgrading our product with ... base and team," says Len Grenier , CEO ...
(Date:11/30/2016)... 2016 Part of 5m$ Investment in ... ... Aptuit, LLC today announced that it had successfully completed the ... compounds have increased the Screening Collection to over 400,000. The ... capabilities of the company. This expansion, complemented by new robotics ...
Breaking Biology Technology:
(Date:11/22/2016)... 2016   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce that the company ... Life Sciences Awards as "Most Outstanding in eClinical ... year of recognition and growth for MedNet, which has ... iMedNet ™ , MedNet,s flagship ...
(Date:11/17/2016)... Calif. , Nov. 17, 2016  AIC announces that it has just released ... in organizations that require high-performance scale-out plus high speed data transfer storage solutions. ... ... ... Setting up a high ...
(Date:11/14/2016)... Technology, Inc. ("xG" or the "Company") (Nasdaq: XGTI, XGTIW), ... in challenging operating environments, announced its results for the ... a conference call to discuss these results on November ... Key Recent Accomplishments ... acquire Vislink Communication Systems. The purchase is expected to ...
Breaking Biology News(10 mins):